Racial Differences in Antihypertensive Therapy: Evidence and Implications

Overview

Journal Cardiovasc Drugs Ther

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 1990 Mar 1

PMID 2271400

Citations 5

Authors

M H Weinberger

Affiliations

Soon will be listed here.

Abstract

Blood pressure is controlled by many factors, and thus hypertension is a multifactorial disorder. This etiologic diversity is also reflected in the broad spectrum of different pharmacologic agents known to lower blood pressure. Most carefully controlled studies employing a single antihypertensive drug in unselected, uncomplicated mild to moderate hypertensives demonstrate efficacy in reducing blood pressure in 40-60% of the population. If two agents of differing pharmacologic actions are combined, success rates of 70-90% are generally observed. Specific choices of antihypertensive agents have heretofore been based on whimsy, hearsay, or empiricism. More recent studies have identified characteristics that may help to predict the efficacy of single drugs. These characteristics have included physiologic factors, such as sodium sensitivity, plasma renin activity, or sympathetic nervous system activity, as well as demographic components, particularly age and race. This review will examine the effects of racial classification on the blood pressure response to antihypertensive agents.

Citing Articles

Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Baba T, Ishizaki T Drugs. 2017; 43(4):464-489.

PMID: 28421556 DOI: 10.2165/00003495-199243040-00004.

Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension.

Baba T, Kodama T, Ishizaki T Eur J Clin Pharmacol. 1993; 45(1):23-7.

PMID: 8405025 DOI: 10.1007/BF00315345.

First line treatment in hypertension.

BMJ. 1991; 302(6768):116.

PMID: 1995112 PMC: 1668910.

Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Todd P, Goa K Drugs. 1992; 43(3):346-81.

PMID: 1374319 DOI: 10.2165/00003495-199243030-00005.

Choosing the correct drug for the individual hypertensive patient.

Opie L Drugs. 1992; 44 Suppl 1:147-55.

PMID: 1283579 DOI: 10.2165/00003495-199200441-00028.

References

Seedat Y . Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br Med J. 1980; 281(6250):1241-3. PMC: 1714681. DOI: 10.1136/bmj.281.6250.1241. View

Weinberger M . Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. Arch Intern Med. 1985; 145(6):1102-5. View

Luft F, Aronoff G, SLOAN R, Fineberg N, Weinberger M . Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans. Hypertension. 1985; 7(3 Pt 1):438-42. View

Levy S, Lilley J, Frigon R, Stone R . Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest. 1977; 60(1):129-38. PMC: 372351. DOI: 10.1172/JCI108749. View

. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967; 202(11):1028-34. View

Weinberger M . Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. Am J Med. 1986; 80(2A):64-70. DOI: 10.1016/0002-9343(86)90162-2. View

CREDITOR M, Loschky U . Incidence of suppressed renin activity and of normokalemic primary aldosteronism in hypertensive Negro patients. Circulation. 1968; 37(6):1027-31. DOI: 10.1161/01.cir.37.6.1027. View

Weinberger M . Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985; 7 Suppl 1:S52-5. DOI: 10.1097/00005344-198507001-00011. View

Cubberley R . Labetalol as monotherapy in hypertensive black patients. J Clin Hypertens. 1985; 1(4):304-14. View

10.

Moser M, Lunn J . Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther. 1982; 32(3):307-12. DOI: 10.1038/clpt.1982.165. View

11.

Hallin L, Andren L, Hansson L . Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol. 1983; 5(6):1083-5. DOI: 10.1097/00005344-198311000-00025. View

12.

Holland O, von Kuhnert L, Campbell W, Anderson R . Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension. 1983; 5(2):235-9. DOI: 10.1161/01.hyp.5.2.235. View

13.

Lijnen P, MBuyamba-Kabangu J, Fagard R, Staessen J, Lissens W, Moerman E . Racial differences in renin, aldosterone, prostaglandin and kallikrein of normal male subjects. Ann Soc Belg Med Trop. 1985; 65(3):293-301. View

14.

Mroczek W, Fotiu S, Davidov M, Finnerty Jr F . Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. Curr Ther Res Clin Exp. 1974; 16(8):769-77. View

15.

Freier P, Wollam G, Hall W, Unger D, DOUGLAS M, Bain R . Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertension. Clin Pharmacol Ther. 1984; 36(6):731-7. DOI: 10.1038/clpt.1984.250. View

16.

Richardson D, Freund J, GEAR A, MAUCK Jr H, Preston L . Effect of propranolol on elevated arterial blood pressure. Circulation. 1968; 37(4):534-42. DOI: 10.1161/01.cir.37.4.534. View

17.

HELMER O, Judson W . Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm. Circulation. 1968; 38(5):965-76. DOI: 10.1161/01.cir.38.5.965. View

18.

CHANNICK B, ADLIN E, Marks A . Suppressed plasma renin activity in hypertension. Arch Intern Med. 1969; 123(2):131-40. View

19.

SCHOENBERGER J, Glasser S, Ram C, McMahon S, Vanov S, Leibowitz D . Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1984; 6 Suppl 7:S1105-8. View

20.

. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988; 148(5):1023-38. View